Alpha-Cure Limited - Accounts to registrar (filleted) - small 18.2

Alpha-Cure Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v19.2.0.596 03191947 Board of Directors Board of Directors 1.1.18 31.12.18 31.12.18 7.8.19 false true false false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure031919472017-12-31031919472018-12-31031919472018-01-012018-12-31031919472016-12-31031919472017-01-012017-12-31031919472017-12-3103191947ns15:EnglandWales2018-01-012018-12-3103191947ns14:PoundSterling2018-01-012018-12-3103191947ns10:Director12018-01-012018-12-3103191947ns10:Director22018-01-012018-12-3103191947ns10:PrivateLimitedCompanyLtd2018-01-012018-12-3103191947ns10:SmallEntities2018-01-012018-12-3103191947ns10:Audited2018-01-012018-12-3103191947ns10:SmallCompaniesRegimeForDirectorsReport2018-01-012018-12-3103191947ns10:SmallCompaniesRegimeForAccounts2018-01-012018-12-3103191947ns10:AbridgedAccounts2018-01-012018-12-310319194712018-01-012018-12-3103191947ns10:Director32018-01-012018-12-3103191947ns10:Director42018-01-012018-12-3103191947ns10:CompanySecretary12018-01-012018-12-3103191947ns10:RegisteredOffice2018-01-012018-12-3103191947ns5:CurrentFinancialInstruments2018-12-3103191947ns5:CurrentFinancialInstruments2017-12-3103191947ns5:Non-currentFinancialInstruments2018-12-3103191947ns5:Non-currentFinancialInstruments2017-12-3103191947ns5:ShareCapital2018-12-3103191947ns5:ShareCapital2017-12-3103191947ns5:CapitalRedemptionReserve2018-12-3103191947ns5:CapitalRedemptionReserve2017-12-3103191947ns5:RetainedEarningsAccumulatedLosses2018-12-3103191947ns5:RetainedEarningsAccumulatedLosses2017-12-3103191947ns5:IntangibleAssetsOtherThanGoodwill2018-01-012018-12-3103191947ns5:PatentsTrademarksLicencesConcessionsSimilar2018-01-012018-12-3103191947ns5:LandBuildingsns5:ShortLeaseholdAssets2018-01-012018-12-3103191947ns5:PlantMachinery2018-01-012018-12-3103191947ns5:FurnitureFittings2018-01-012018-12-3103191947ns5:Secured2018-12-3103191947ns5:Secured2017-12-31031919473ns10:Director32017-12-31031919473ns10:Director32016-12-31031919473ns10:Director32018-01-012018-12-31031919473ns10:Director32017-01-012017-12-31031919473ns10:Director32018-12-31031919473ns10:Director32017-12-3103191947ns10:Director112017-12-3103191947ns10:Director112016-12-3103191947ns10:Director112018-01-012018-12-3103191947ns10:Director112017-01-012017-12-3103191947ns10:Director112018-12-3103191947ns10:Director112017-12-3103191947ns10:Director222017-12-3103191947ns10:Director222016-12-3103191947ns10:Director222018-01-012018-12-3103191947ns10:Director222017-01-012017-12-3103191947ns10:Director222018-12-3103191947ns10:Director222017-12-31


REGISTERED NUMBER: 03191947 (England and Wales)















Financial Statements for the Year Ended 31 December 2018

for

Alpha-Cure Limited

Alpha-Cure Limited (Registered number: 03191947)






Contents of the Financial Statements
for the Year Ended 31 December 2018




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


Alpha-Cure Limited

Company Information
for the Year Ended 31 December 2018







DIRECTORS: S P Atherstone
S Haines
M A Slater
K Baier



SECRETARY: M A Slater



REGISTERED OFFICE: Leonard House
Great Central Way
Woodford Halse
Daventry
Northamptonshire
NN11 3PZ



REGISTERED NUMBER: 03191947 (England and Wales)



AUDITORS: CED Accountancy Services Limited
Registered Auditors
Chartered Accountants
1 Lucas Bridge Business Park
Old Greens Norton Road
Towcester
Northamptonshire
NN12 8AX



BANKERS: National Westminster Bank Plc
Grange Park Court
Roman Way
Grange Park
Northampton
NN4 5EA



SOLICITORS: Howes Percival
Oxford House
Northampton
Northamptonshire
NN1 5PN

Alpha-Cure Limited (Registered number: 03191947)

Abridged Balance Sheet
31 December 2018

31.12.18 31.12.17
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 2,105 2,393
Tangible assets 5 633,622 546,545
635,727 548,938

CURRENT ASSETS
Stocks 1,098,511 853,383
Debtors 2,290,172 2,464,786
Cash at bank - 152,059
3,388,683 3,470,228
CREDITORS
Amounts falling due within one year 2,671,685 2,993,609
NET CURRENT ASSETS 716,998 476,619
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,352,725

1,025,557

CREDITORS
Amounts falling due after more than one
year

(76,109

)

(35,209

)

PROVISIONS FOR LIABILITIES (111,904 ) (93,319 )
NET ASSETS 1,164,712 897,029

CAPITAL AND RESERVES
Called up share capital 95 95
Capital redemption reserve 5 5
Retained earnings 1,164,612 896,929
SHAREHOLDERS' FUNDS 1,164,712 897,029

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31 December 2018 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

Alpha-Cure Limited (Registered number: 03191947)

Abridged Balance Sheet - continued
31 December 2018



The financial statements were approved by the Board of Directors on 7 August 2019 and were signed on its behalf by:




S Haines - Director



M A Slater - Director


Alpha-Cure Limited (Registered number: 03191947)

Notes to the Financial Statements
for the Year Ended 31 December 2018

1. STATUTORY INFORMATION

Alpha-Cure Limited is a private company, limited by shares , registered in England and Wales. The company's
registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates,
value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost
less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of twenty years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Short leasehold - 15% on cost
Plant and machinery - 15% on reducing balance
Fixtures and fittings - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow
moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and
Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or
directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or
substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from
those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that
have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the
timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they
will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Alpha-Cure Limited (Registered number: 03191947)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2018

2. ACCOUNTING POLICIES - continued

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the
balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at
the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held
under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases
are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element
of the future payments is treated as a liability.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension
scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 48 (2017 - 43 ) .

4. INTANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 January 2018
and 31 December 2018 5,727
AMORTISATION
At 1 January 2018 3,334
Amortisation for year 288
At 31 December 2018 3,622
NET BOOK VALUE

At 31 December 2018 2,105
At 31 December 2017 2,393

Alpha-Cure Limited (Registered number: 03191947)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2018

5. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 January 2018 1,675,971
Additions 190,359
At 31 December 2018 1,866,330
DEPRECIATION
At 1 January 2018 1,129,426
Charge for year 103,282
At 31 December 2018 1,232,708
NET BOOK VALUE
At 31 December 2018 633,622
At 31 December 2017 546,545

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Totals
£   
COST
At 1 January 2018 209,874
Additions 77,773
Transfer to ownership (93,996 )
At 31 December 2018 193,651
DEPRECIATION
At 1 January 2018 111,604
Charge for year 11,394
Transfer to ownership (71,690 )
At 31 December 2018 51,308
NET BOOK VALUE
At 31 December 2018 142,343
At 31 December 2017 98,270

Alpha-Cure Limited (Registered number: 03191947)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2018

6. SECURED DEBTS

The following secured debts are included within creditors:

31.12.18 31.12.17
£    £   
Bank overdraft 4,577 -
Bank loans - 20,506
Other loans 150,000 37,807
Hire purchase contracts 111,262 68,327
265,839 126,640

National Westminster Bank Plc hold a debenture dated 2 January 2007 including a first fixed charge on book
debts and other debts.

All finance lease and hire purchase contracts are secured on assets financed (see note 6).

7. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Clifford Davidson BSc FCA (Senior Statutory Auditor)
for and on behalf of CED Accountancy Services Limited

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 December 2018 and
31 December 2017:

31.12.18 31.12.17
£    £   
S P Atherstone
Balance outstanding at start of year 21,107 21,107
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 21,107 21,107

S Haines
Balance outstanding at start of year 82 496
Amounts repaid - (414 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 82 82

M A Slater
Balance outstanding at start of year 15,815 37,298
Amounts advanced 8,000 41,000
Amounts repaid - (62,483 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 23,815 15,815

Alpha-Cure Limited (Registered number: 03191947)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2018

9. RELATED PARTY DISCLOSURES

The parent company of Alpha-Cure Limited is Alpha-Cure Holdings Ltd.

SalesPurchasesCreditorDebtor
Transactions with
controlling entity


414,551
Transactions with group
companies

538,730

3,051,209

1,264,423

64,638
Transactions with other
related parties

73,409


35,213

The company also received a loan from the Retirement Benefit Pension Scheme of £150,000.

10. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Alpha-Cure Holdings Limited (a Company registered in England and Wales) by
virtue of its majority shareholding.